Conversation with The Cancer Letter Nobel Prize-winning technology may enable delivery of up to 12x the standard doxorubicin dose July 28, 2023Vol.49 No.30By Jacquelyn Cobb
Conversation with The Cancer Letter St. Jude’s Heather Brandt: NCI cancer centers must leverage community trust to boost HPV vaccine uptake in children July 21, 2023Vol.49 No.29By Matthew Bin Han Ong
Conversation with The Cancer Letter NCI’s Douglas Lowy: HPV vaccination is important, but it’s even more important to get screened July 21, 2023Vol.49 No.29By Matthew Bin Han Ong
Conversation with The Cancer Letter Once deemed a “functional wasteland,” Y chromosome is found to play a role in cancer immunityThe finding may alter biology textbooks July 07, 2023Vol.49 No.27By Jacquelyn Cobb
Conversation with The Cancer Letter Robert Winn: Overreaction to the Supreme Court ruling that bars affirmative action is a greater threat than the ruling itself June 30, 2023Vol.49 No.26By Paul Goldberg and Matthew Bin Han Ong
Conversation with The Cancer Letter KU Cancer Center receives $100 million for a research and outpatient building June 30, 2023Vol.49 No.26By Paul Goldberg
Conversation with The Cancer Letter Jonathan Licht describes University of Florida’s seven-year leap to NCI designation June 23, 2023Vol.49 No.25By Paul Goldberg
Conversation with The Cancer LetterFree Robert Winn tells us how he led VCU Massey to obtain Comprehensive designation May 31, 2023Vol.49 No.22By Paul Goldberg
Conversation with The Cancer LetterFree Richard Pazdur discusses root causes of cisplatin and carboplatin shortage and what can be done to alleviate it May 30, 2023Vol.49 No.22By Paul Goldberg
Conversation with The Cancer Letter ASCO’s Julie Gralow: At least 100,000 (and up to 500,000) cancer patients affected by cisplatin, carboplatin shortage May 26, 2023Vol.49 No.21By Paul Goldberg
